The ISoP standards and best practices committee

R. Bruno; F. Mentré; S. Tannenbaum; Y. Wang; B. Corrigan; D. E. Mager

doi:10.1038/clpt.2014.65

The ISoP standards and best practices committee

R. Bruno
, F. Mentré
, S. Tannenbaum
, Y. Wang
, B. Corrigan
, D. E. Mager

Pharmaceutical Sciences

Certara
UMR 1137
Astellas Pharma Inc.
United States Food and Drug Administration
Pfizer

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Abstract

The mission of the International Society of Pharmacometrics (ISoP) Standards and Best Practices Committee is to provide best practices and recommendations for standard pharmacometric analyses - e.g., population pharmacokinetics/pharmacodynamics (PK/PD), exposure-response, disease models - with the goal of increasing consistency, productivity, quality, communication, and impact of pharmacometrics on decision making. We present the progress and plans of the committee and call for volunteers to start new initiatives.

Original language	English
Pages (from-to)	581-582
Number of pages	2
Journal	Clinical Pharmacology and Therapeutics
Volume	95
Issue number	6
DOIs	https://doi.org/10.1038/clpt.2014.65
State	Published - Jun 2014

Access to Document

10.1038/clpt.2014.65

Cite this

@article{071b52063acf41bc995968ad5476e4fb,

title = "The ISoP standards and best practices committee",

abstract = "The mission of the International Society of Pharmacometrics (ISoP) Standards and Best Practices Committee is to provide best practices and recommendations for standard pharmacometric analyses - e.g., population pharmacokinetics/pharmacodynamics (PK/PD), exposure-response, disease models - with the goal of increasing consistency, productivity, quality, communication, and impact of pharmacometrics on decision making. We present the progress and plans of the committee and call for volunteers to start new initiatives.",

author = "R. Bruno and F. Mentr{\'e} and S. Tannenbaum and Y. Wang and B. Corrigan and Mager, \{D. E.\}",

year = "2014",

month = jun,

doi = "10.1038/clpt.2014.65",

language = "English",

volume = "95",

pages = "581--582",

journal = "Clinical Pharmacology and Therapeutics",

issn = "0009-9236",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - JOUR

T1 - The ISoP standards and best practices committee

AU - Bruno, R.

AU - Mentré, F.

AU - Tannenbaum, S.

AU - Wang, Y.

AU - Corrigan, B.

AU - Mager, D. E.

PY - 2014/6

Y1 - 2014/6

N2 - The mission of the International Society of Pharmacometrics (ISoP) Standards and Best Practices Committee is to provide best practices and recommendations for standard pharmacometric analyses - e.g., population pharmacokinetics/pharmacodynamics (PK/PD), exposure-response, disease models - with the goal of increasing consistency, productivity, quality, communication, and impact of pharmacometrics on decision making. We present the progress and plans of the committee and call for volunteers to start new initiatives.

AB - The mission of the International Society of Pharmacometrics (ISoP) Standards and Best Practices Committee is to provide best practices and recommendations for standard pharmacometric analyses - e.g., population pharmacokinetics/pharmacodynamics (PK/PD), exposure-response, disease models - with the goal of increasing consistency, productivity, quality, communication, and impact of pharmacometrics on decision making. We present the progress and plans of the committee and call for volunteers to start new initiatives.

UR - https://www.scopus.com/pages/publications/84901022577

U2 - 10.1038/clpt.2014.65

DO - 10.1038/clpt.2014.65

M3 - Review article

C2 - 24842638

AN - SCOPUS:84901022577

SN - 0009-9236

VL - 95

SP - 581

EP - 582

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

IS - 6

ER -

The ISoP standards and best practices committee

Abstract

Access to Document

Other files and links

Fingerprint

Cite this